West Oak Capital’s Boston Scientific BSX Stock Holding History

West Oak Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$708	Buy	725 +400	+123%	+$41.4K	0.03%	149
2025 Q2	$349	Hold	325	–	–	0.01%	184
2025 Q1	$328	Hold	325	–	–	0.01%	193
2024 Q4	$290K	Buy	+325	New	+$28.6K	0.01%	196
2022 Q2	–	Sell	-200	Closed	-$9K	–	329
2022 Q1	$9K	Hold	200	–	–	﹤0.01%	266
2021 Q4	$8K	Sell	200 -500	-71%	-$21K	﹤0.01%	279
2021 Q3	$30K	Buy	700 +200	+40%	+$8.85K	0.01%	215
2021 Q2	$21K	Hold	500	–	–	0.01%	234
2021 Q1	$19K	Hold	500	–	–	0.01%	231
2020 Q4	$18K	Hold	500	–	–	0.01%	223
2020 Q3	$19K	Sell	500 -175	-26%	-$6.74K	0.01%	198
2020 Q2	$24K	Hold	675	–	–	0.01%	196
2020 Q1	$22K	Sell	675 -550	-45%	-$21.5K	0.02%	189
2019 Q4	$55K	Sell	1,225 -1,050	-46%	-$43.9K	0.03%	169
2019 Q3	$93K	Hold	2,275	–	–	0.05%	148
2019 Q2	$98K	Hold	2,275	–	–	0.06%	143
2019 Q1	$87K	Buy	2,275 +1,225	+117%	+$46.8K	0.05%	145
2018 Q4	$37.1K	Buy	1,050 +300	+40%	+$10.9K	0.03%	179
2018 Q3	$28.9K	Buy	+750	New	+$26.2K	0.02%	209

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

West Oak Capital's BSX Position: Q3 2025 in Review

West Oak Capital increased its Boston Scientific (BSX) stake by 123% in Q3 2025, buying an estimated $41.4K and bringing the position to 725 shares worth $708. The position accounts for 0.03% of the portfolio, ranked #149.

West Oak Capital first reported a position in BSX in Q3 2018 and has held it in 19 quarters since. The position peaked at $290K in Q4 2024. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

West Oak Capital held 725 shares of Boston Scientific worth $708 as of Q3 2025.
West Oak Capital bought 400 Boston Scientific shares in Q3 2025, an estimated $41.4K.
Boston Scientific made up 0.03% of West Oak Capital's portfolio in Q3 2025, its #149 holding.
West Oak Capital first reported a position in Boston Scientific in Q3 2018 and has held it in 19 quarters since.
West Oak Capital's Boston Scientific position peaked at $290K in Q4 2024.
1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on West Oak Capital's 13F filing for Q3 2025, filed 3 Oct 2025.